Loading company…
ID 400327008 · FY 2022–2023 · 2 years
1.2 კომპანიის ძირითად საქმიანობას წარმოადგენს: - საბითუმო ვაჭრობა ფარმაცევტული საქონლით თავისუფალ ინდუსტრიულ ზონაში 1.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Line item | 2022 | 2023 | CAGR |
|---|---|---|---|
| Total Current Assets | 8,813 | 19,259 | +118.5% |
| Total Non-Current Assets | 0 | 2 | |
| TOTAL ASSETS | 8,813 | 19,262 | +118.6% |
| Total Current Liabilities | 3,950 | 5,548 | +40.4% |
| Total Non-Current Liabilities | 0 | 0 | -94.9% |
| TOTAL LIABILITIES | 3,951 | 5,548 | +40.4% |
| Total Equity | 4,862 | 13,713 | +182.1% |
| Balance Check (Assets - L&E) | 0 | 0 | |
| Debt analysis | |||
| Total Debt | 0 | 0 | |
| Cash & Equivalents | 682 | 1 | nmf |
| Net Debt | -682 | -1 | nmf |
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.